Precision BioSciences expands hepatitis B trial to France and Romania

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. IBM
4. SPCX
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. DPZ

Go back to Precision BioSciences expands hepatitis B trial to France and Romania
(NASDAQ: DTIL) Delayed: 7.16 +0.08 (1.13%)
Previous Close $7.08    52 Week High $ 
Open $6.98    52 Week Low $ 
Day High $7.30    P/E N/A 
Day Low $6.77    EPS $ 
Volume 71,429